Stock 2395 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Shin Nippon Biomedical Laboratories, Ltd.

Equities

2395

JP3379950003

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-31 am EDT 		5-day change 1st Jan Change
1,358 JPY +2.03% Intraday chart for Shin Nippon Biomedical Laboratories, Ltd. +4.38% -20.02%
May. 08 Shin Nippon Biomedical Laboratories, Ltd. Announces Fiscal Year End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 25, 2024; Provides Second Quarter End and Fiscal Year End Dividend Guidance for the Fiscal Year Ended March 31, 2025 CI
May. 08 Shin Nippon Biomedical Laboratories, Ltd. Provides Consolidated Earnings Forecasts for the Six Months Ending September 30, 2024 and Year Ending March 31, 2025 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shin Nippon Biomedical Laboratories : 英語版 株主通信（2023/04/01~2023/09/30）を発行しました
PU
Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be presented at the American Headache Society's 65th Annual Scientific Meeting
AQ
Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting
AQ
Shin Nippon Biomedical Laboratories : Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023 (Under Japanese GAAP)
PU
Shin Nippon Biomedical Laboratories : Presentation materials for the First Three Months of the Fiscal Year Ending March 31, 2023
PU
Shin Nippon Biomedical Laboratories : Notice Regarding Revisions of the Earnings Forecasts for the Six Months and Full-Year of the Fiscal Year Ending March 31, 2023
PU
Shin Nippon Biomedical Laboratories : Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2022 (Under Japanese GAAP)
PU
Shin Nippon Biomedical Laboratories : Notice Regarding Revisions of Consolidated Earnings and Dividend Forecasts for the Full-Year of the Fiscal Year Ending March 31,2022
PU
Shin Nippon Biomedical Laboratories : Supplementary Material on Quarterly Financial Results
PU
Supplementary Material on 1H Financial Results
PU
Shin Nippon Biomedical Laboratories : Notice Regarding Revisions of the Earnings Forecasts for the Six Months and Full Year of the Fiscal Year Ending March 31, 2022
PU
Shin Nippon Biomedical Laboratories : Notice Regarding Establishment of SDGs Committee
PU
Shin Nippon Biomedical Laboratories : Health & Productivity Award 2019
PU
Shin Nippon Biomedical Laboratories : SNBL will give a preclinical seminar in Taiwan
PU
Shin Nippon Biomedical Laboratories : 2018 Prime Minister's Award
PU
Shin Nippon Biomedical Laboratories : MHLW Award of Excellence
PU
Shin Nippon Biomedical Laboratories : Conclusion of Memorandum of Understanding with Medgaea Life Sciences Ltd. for Cooperative Relationship
PU
Shin Nippon Biomedical Laboratories : Investment in Trunk Solution Corporation (TSC)
PU
Shin Nippon Biomedical Laboratories : Wings of Dreams
PU
Shin Nippon Biomedical Laboratories : Another Ophthalmologist
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2395 Stock
  4. News Shin Nippon Biomedical Laboratories, Ltd.
  5. Press Releases